Assistant Professor; Joint Faculty, Department of Microbiology and Immunology
Division of Hematology
Area of Interest
The Vincent Lab works in the areas of systems tumor immunology and immunogenomics, to better understand anti-tumor immunity and translate this into curative immunotherapy strategies.
Awards and Honors
- Biological and Biomedical Sciences Faculty Mentor Award, UNC-Chapel Hill, 2022
- Invited speaker, Immuno-Oncology Young Investigators Forum, 2016
- Pope Clinical Fellow Award, Lineberger Comprehensive Cancer Center, 2015
- Outstanding Fellow Award, North Carolina Oncology Association, 2015
- Invited speaker, Illumina Users Group Meeting, 2015
- Outstanding Abstract Travel Award, American Society of Hematology, 2013
- Farmer Award for Compassion in Medicine, UNC Hospitals Department of Internal Medicine, 2010
- David A. Ontjes Outstanding Intern Award, UNC Hospitals Department of Internal Medicine, 2010
- Competitive Selection to ABIM Research Track, UNC Department of Hematology/Oncology, 2009
- John B. Graham Medical Student Research Society, University of North Carolina, 2008
- Harold C. Pillsbury Basic Science Award, University of North Carolina School of Medicine, 2008
- Holderness Research Fellowship, University of North Carolina School of Medicine, 2005
News and Stories
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies
UNC Lineberger researchers have found a possible way to overcome barriers that block anti-cancer immune responses. Their findings could have implications for treating solid tumors, including breast and pancreatic cancer.
Loved ones battling cancer inspire donor’s gift
After seeing friends and family members struggle with cancer and tired of feeling helpless, Betsy Jordan decided to do something about it by making a gift to support innovative research.
A patient’s decision adds immeasurably to knowledge about how to treat lung cancer
Chad Pecot, MD, and colleagues used biospecimens from a patient just after he succumbed to lung cancer to unravel how a KRAS mutation developed resistance to a treatment that had initially proved effective.